The results showed that the siRNA-containing EVs were able to successfully target downregulation of the KRAS gene in cancer cells, which considerably extended the lifespans of mice, while also effectively suppressing tumor growth and promoting apoptosis in tumor tissues. Here, KRAS is linked to neoplasm.